Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the TAM Receptors in Leukemia
Madeline G. Huey, Katherine A. Minson, H. Shelton Earp, et al.
Cancers (2016) Vol. 8, Iss. 11, pp. 101-101
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
Jenna L. Carter, Katie Hege, Jay Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 165
Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment
Mai Tanaka, Dietmar W. Siemann
Cancers (2020) Vol. 12, Iss. 7, pp. 1850-1850
Open Access | Times Cited: 107
Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer
Canan Kasikara, Viralkumar Davra, David Calianese, et al.
Cancer Research (2019) Vol. 79, Iss. 10, pp. 2669-2683
Closed Access | Times Cited: 94
Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity
Viralkumar Davra, Sushil Kumar, Ke Geng, et al.
Cancer Research (2020) Vol. 81, Iss. 3, pp. 698-712
Open Access | Times Cited: 71
Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics
M Sreepadmanabh, Bhushan J. Toley
Biotechnology Advances (2018) Vol. 36, Iss. 4, pp. 1094-1110
Closed Access | Times Cited: 54
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
Nellie K. McDaniel, Christopher T. Cummings, Mari Iida, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 11, pp. 2297-2308
Open Access | Times Cited: 48
MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells
Marlies J. W. Peeters, Donata Dulkeviciute, Arianna Draghi, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 9, pp. 1472-1484
Open Access | Times Cited: 47
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
Solène Fernandez, Vanessa Desplat, Arnaud Villacreces, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3429-3429
Open Access | Times Cited: 39
TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
Marlies J. W. Peeters, Anne Rahbech, Per thor Straten
Cancer Immunology Immunotherapy (2019) Vol. 69, Iss. 2, pp. 237-244
Open Access | Times Cited: 37
Immune Evasion Mechanism and AXL
Hye‐Youn Son, Hwan-Kyu Jeong
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 31
Mertk: An emerging target in cancer biology and immuno-oncology
Kevin C. Lahey, Varsha Gadiyar, Amanda A. Hill, et al.
International review of cell and molecular biology (2022), pp. 35-59
Open Access | Times Cited: 22
Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?
Danfeng Lin, Xiaodiao Kang, Lu Shen, et al.
Molecular Therapy — Oncolytics (2020) Vol. 17, pp. 394-407
Open Access | Times Cited: 31
Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
Dan Yan, H. Shelton Earp, Deborah DeRyckere, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5639-5639
Open Access | Times Cited: 24
A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
Ahmad Nasimian, Lina Al Ashiri, Mehreen Ahmed, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3830-3830
Open Access | Times Cited: 10
Navigating TAM receptor dynamics in tumour immunotherapy
Jihao Yang, Guanmin Chen, Rui Wang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review
Arash Letafati, Roben Soheili, Mehdi Norouzi, et al.
Medical Oncology (2023) Vol. 40, Iss. 10
Closed Access | Times Cited: 8
Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms
Peter P. Ruvolo, Huaxian Ma, Vivian Ruvolo, et al.
Haematologica (2017) Vol. 102, Iss. 12, pp. 2048-2057
Open Access | Times Cited: 25
TAM kinase inhibition and immune checkpoint blockade– a winning combination in cancer treatment?
Pavlos Msaouel, Giannicola Genovese, Jianjun Gao, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 25, Iss. 2, pp. 141-151
Closed Access | Times Cited: 21
The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia
Nathan Gossai, Peter M. Gordon
Frontiers in Pediatrics (2017) Vol. 5
Open Access | Times Cited: 24
AXL, an Important Host Factor for DENV and ZIKV Replication
Shengda Xie, Huiru Zhang, Zhenjie Liang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 16
TAM kinases as regulators of cell death
Sean M. Post, Michael Andreeff, Courtney D. DiNardo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2021) Vol. 1868, Iss. 6, pp. 118992-118992
Open Access | Times Cited: 15
Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling
Mai Tanaka, Samantha S. Dykes, Dietmar W. Siemann
Clinical & Experimental Metastasis (2021) Vol. 38, Iss. 3, pp. 321-335
Open Access | Times Cited: 13
The effects of vitamin K1 and vitamin K2 on the proliferation, cytokine production and regulatory T‐cell frequency in peripheral blood mononuclear cells of paediatric atopic dermatitis patients
Kehan Meng, Wencheng Xu, Taro Miura, et al.
Experimental Dermatology (2018) Vol. 27, Iss. 9, pp. 1058-1060
Closed Access | Times Cited: 15
Enhanced metastable state models of TAM kinase binding to cabozantinib explains the dynamic nature of receptor tyrosine kinases
Gatta K. R. S. Naresh, Lalitha Guruprasad
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 4, pp. 1213-1235
Closed Access | Times Cited: 8
Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase
Tatsuya Saito, Mai Itoh, Shuji Tohda
Leukemia Research (2020) Vol. 94, pp. 106383-106383
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top